BSX 財務： Boston Scientific Corp AI 分析

首頁

股票

BSX

財務狀況

BSX 財務

Boston Scientific Corp

$69.52

2.01%

$1.36

截至今日：Mar 25, 15:24:08 GMT-4

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

BSX 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
營收	20,075	20,074	16,747	14,240	12,682	11,888
營收年增率 (YoY)	20%	20%	18%	12%	7%	20%
營收成本	6,222	6,221	5,238	4,322	3,932	3,681
毛利	13,853	13,853	11,509	9,918	8,750	8,207
銷售、一般及管理費用	6,888	6,887	5,984	5,190	4,520	4,287
研發	2,052	2,052	1,615	1,414	1,323	1,204
營業費用	9,854	9,853	8,452	7,490	6,679	6,095
其他非營業收入 (費用)	133	-35	-28	-15	-16	-9
稅前淨利	3,385	3,385	2,282	1,985	1,141	1,076
所得稅費用	492	493	436	393	443	36
淨利	2,898	2,898	1,853	1,570	642	985
淨利成長	56%	56%	18%	145%	-35%	-957%
稀釋後流通股數	1,496	1,494.5	1,485.9	1,463.5	1,439.7	1,433.8
股數年變動 (YoY)	0%	1%	2%	2%	0%	1%
每股盈餘 (稀釋)	1.92	1.93	1.25	1.07	0.45	0.69
每股盈餘成長率	54%	55%	17%	138%	-35%	-963%
自由現金流	3,658	3,658	2,644	1,792	938	1,317
每股自由現金流	--	--	--	--	--	--
毛利率	69%	69%	68.72%	69.64%	68.99%	69.03%
營業利益率	19.92%	19.92%	18.25%	17.05%	16.33%	17.76%
淨利率	14.43%	14.43%	11.06%	11.02%	5.06%	8.28%
自由現金流利潤率	18.22%	18.22%	15.78%	12.58%	7.39%	11.07%
EBITDA	4,896	4,897	3,913	3,256	2,874	2,853
EBITDA 利潤率	24.38%	24.39%	23.36%	22.86%	22.66%	23.99%
EBITDA 中的折舊與攤銷	897	897	856	828	803	741
EBIT	3,999	4,000	3,057	2,428	2,071	2,112
EBIT 利潤率	19.92%	19.92%	18.25%	17.05%	16.33%	17.76%
有效稅率	14.53%	14.56%	19.1%	19.79%	38.82%	3.34%

Follow-Up Questions

Boston Scientific Corp 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Boston Scientific Corp 的總資產為 $43,673，淨利潤為 $2,898

BSX 的關鍵財務比率是什麼？



Boston Scientific Corp 的流動比率為 2.24，淨利潤率為 14.43，每股銷售為 $13.43。

Boston Scientific Corp 的收入按細分市場或地理位置如何劃分？



Boston Scientific Corp 最大收入來源為 Other，在最近的收益報告中收入為 -1,000,000。就地區而言，U.S 是 Boston Scientific Corp 的主要市場，收入為 12,864,000,000。

Boston Scientific Corp 是否盈利？



是的，根據最新的財務報表，Boston Scientific Corp 的淨利潤為 $2,898

Boston Scientific Corp 有負債嗎？



是的，Boston Scientific Corp 的負債為 19,440

Boston Scientific Corp 的流通股有多少？



Boston Scientific Corp 的總流通股為 1,483

關鍵數據

前收市價

$68.15

開盤價

$69

當日範圍

$68.6 - $70.1

52週區間

$67.56 - $109.5

交易量

5.2M

平均成交量

14.5M

股息收益率

0.00%

每股盈餘 (TTM)

1.94

市值

$103.0B

什麼是 BSX？

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

功能特性

資源